A major trial led by the University of Bristol and North Bristol NHS Trust is exploring a panel of blood tests to detect dementia faster and more accurately across diverse UK populations.
There is a beacon of hope for patients with a rare genetic disorder called Werner Syndrome as researchers unveil a groundbreaking discovery: Nicotinamide riboside, a vitamin B3 derivative, reverses premature ageing.
MS Australia is a national not-for-profit organisation dedicated to improving the lives of those affected by multiple sclerosis. Its remit includes supporting research for...
New research has found that consuming foods rich in flavonoids, such as tea and dark chocolate, could lower their risk of developing health conditions and increase longevity.
Having a pet dog may lower the risk of eczema in children who are genetically prone to the condition, shedding light on how environmental factors may influence genetic risks.
Chronic wounds present a huge social and economic burden; Consultant Podiatrist Debbie Sharman shares the importance of the Legs Matter coalition, which includes various healthcare charities dedicated to improving care for individuals with diabetic foot problems and other lower limb conditions.
An experimental drug known as ulefnersen has shown remarkable efficacy in treating a rare, aggressive form of ALS. Some patients experienced unprecedented functional recovery, offering new hope in a previously devastating diagnosis.
A new study reveals that adults diagnosed with type 1 diabetes face a heightened risk of cardiovascular disease and death, with no better prognosis than those diagnosed in childhood.
A major clinical trial has found that low-dose interleukin-2 (IL2LD) is safe and may significantly extend survival in people with motor neurone disease (ALS).
